Fangcheng Zhang

720 total citations
34 papers, 530 citations indexed

About

Fangcheng Zhang is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Fangcheng Zhang has authored 34 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Fangcheng Zhang's work include Meningioma and schwannoma management (9 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). Fangcheng Zhang is often cited by papers focused on Meningioma and schwannoma management (9 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). Fangcheng Zhang collaborates with scholars based in China and United States. Fangcheng Zhang's co-authors include Hongyang Zhao, Xiaobing Jiang, Nanxiang Xiong, Peng-Fei Yan, Deqiang Lei, Jun Feng, Min Feng, Hongyang Zhao, Xiaoling Lü and Dongxiao Yao and has published in prestigious journals such as Clinical Cancer Research, Cancer Letters and Medicine.

In The Last Decade

Fangcheng Zhang

33 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangcheng Zhang China 14 188 128 109 96 91 34 530
Lunshan Xu China 18 357 1.9× 122 1.0× 100 0.9× 93 1.0× 173 1.9× 33 682
Young Cha South Korea 15 473 2.5× 95 0.7× 58 0.5× 54 0.6× 121 1.3× 25 772
Min Chao China 11 232 1.2× 61 0.5× 65 0.6× 116 1.2× 130 1.4× 31 449
Sylvaine Guérit Germany 9 343 1.8× 66 0.5× 77 0.7× 62 0.6× 129 1.4× 13 747
Xifeng Fei China 14 301 1.6× 120 0.9× 64 0.6× 103 1.1× 231 2.5× 38 606
Houshi Xu China 13 216 1.1× 76 0.6× 135 1.2× 71 0.7× 116 1.3× 29 500
Kenichiro Matsuda Japan 9 435 2.3× 192 1.5× 38 0.3× 246 2.6× 160 1.8× 35 694
Julie Dwyer France 13 415 2.2× 167 1.3× 111 1.0× 80 0.8× 142 1.6× 14 700
Jae-Bong Park South Korea 13 399 2.1× 100 0.8× 68 0.6× 37 0.4× 68 0.7× 24 623
Brian Golbourn Canada 14 334 1.8× 116 0.9× 25 0.2× 167 1.7× 125 1.4× 24 676

Countries citing papers authored by Fangcheng Zhang

Since Specialization
Citations

This map shows the geographic impact of Fangcheng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangcheng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangcheng Zhang more than expected).

Fields of papers citing papers by Fangcheng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangcheng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangcheng Zhang. The network helps show where Fangcheng Zhang may publish in the future.

Co-authorship network of co-authors of Fangcheng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fangcheng Zhang. A scholar is included among the top collaborators of Fangcheng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangcheng Zhang. Fangcheng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qiangping, Shuang Li, Wenjie Wu, et al.. (2024). RNF13 protects neurons against ischemia-reperfusion injury via stabilizing p62-mediated Nrf2/HO-1 signaling pathway. Cell Communication and Signaling. 22(1). 535–535. 7 indexed citations
2.
Wang, Haijun, et al.. (2022). Case Report: Extensive Temporal Bone Invasion in a Giant Vestibular Schwannoma. Frontiers in Surgery. 9. 759163–759163. 1 indexed citations
3.
Qian, Kang, et al.. (2022). Surgical management of tuberculum sellae meningioma: Transcranial approach or endoscopic endonasal approach?. Frontiers in Surgery. 9. 979940–979940. 10 indexed citations
4.
Zhang, Yanling, et al.. (2021). Current Understanding of Hearing Loss in Sporadic Vestibular Schwannomas: A Systematic Review. Frontiers in Oncology. 11. 687201–687201. 17 indexed citations
5.
6.
Wang, Yihao, Fangcheng Zhang, Nanxiang Xiong, et al.. (2021). Remodelling and Treatment of the Blood-Brain Barrier in Glioma. Cancer Management and Research. Volume 13. 4217–4232. 37 indexed citations
7.
Yan, Peng-Fei, et al.. (2020). Expression of Microrna-210 and the Prognosis in Glioma Patients: A Meta-Analysis. Biomarkers in Medicine. 14(9). 795–805. 5 indexed citations
8.
Lei, Deqiang, Dongxiao Yao, Fangcheng Zhang, et al.. (2020). Efficacy of unilateral hemilaminectomy for intraspinal tumor resection: a systematic review and meta-analysis. Annals of Palliative Medicine. 10(2). 984–999. 9 indexed citations
9.
Cheng, Dan, et al.. (2019). An unusual case report of multiple pulmonary leiomyomatous hamartoma. Medicine. 98(30). e16496–e16496. 3 indexed citations
10.
Lei, Deqiang, et al.. (2017). MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomedicine & Pharmacotherapy. 89. 957–965. 42 indexed citations
11.
Feng, Jun, et al.. (2016). Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway. BioMed Research International. 2016. 1–11. 45 indexed citations
12.
13.
Wang, Xuan, Xiaoling Lü, Hongyang Zhao, Fangcheng Zhang, & Xiaobing Jiang. (2013). A novel recombinant protein of IP10-EGFRvIIIscFv and CD8+ cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice. Cancer Immunology Immunotherapy. 62(7). 1261–1272. 32 indexed citations
14.
Xiong, Nanxiang, Hongyang Zhao, Fangcheng Zhang, & Ruen Liu. (2012). Vagoglossopharyngeal Neuralgia Treated by Microvascular Decompression and Glossopharyngeal Rhizotomy: Clinical Results of 21 Cases. Stereotactic and Functional Neurosurgery. 90(1). 45–50. 21 indexed citations
15.
Jiang, Xiaobing, Xiaoling Lü, Ruen Liu, Fangcheng Zhang, & Hongyang Zhao. (2007). Induction of Cytotoxic T-Lymphocytes Specific for Malignant Glioma by HLA Dimer-Based Artificial Antigen-Presenting Cells. Cancer Biotherapy and Radiopharmaceuticals. 22(6). 826–835. 1 indexed citations
16.
Jiang, Xiaobing, Xiaoling Lü, Ruen Liu, Fangcheng Zhang, & Hongyang Zhao. (2007). HLA Tetramer–Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma. Clinical Cancer Research. 13(24). 7329–7334. 18 indexed citations
17.
Lü, Xiaoling, Xiaobing Jiang, Ruen Liu, Fangcheng Zhang, & Hongyang Zhao. (2007). Generation of allo-restricted cytotoxic T lymphocytes against malignant glioma by artificial antigen-presenting cells. Cancer Letters. 256(1). 128–135. 5 indexed citations
18.
Jiang, Xiaobing, Xiaoling Lü, Ruen Liu, Fangcheng Zhang, & Hongyang Zhao. (2007). Induction of Cytotoxic T Lymphocytes Specific to Malignant Glioma Using T2 Cells Pulsed with HLA-A2-restricted Interleukin-13 Receptor α2 Peptide <italic>in vitro</italic>. Acta Biochimica et Biophysica Sinica. 39(9). 641–648. 5 indexed citations
19.
Xiong, Nanxiang, et al.. (2007). Negative correlation of Nogo-A with the malignancy of oligodendroglial tumor. Neuroscience Bulletin. 23(1). 41–45. 14 indexed citations
20.
Jiang, Xiaobing, et al.. (2005). [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].. PubMed. 85(8). 547–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lunshan Xu Breakdown of academic impact, for papers by Young Cha Breakdown of academic impact, for papers by Min Chao Breakdown of academic impact, for papers by Sylvaine Guérit Breakdown of academic impact, for papers by Xifeng Fei Breakdown of academic impact, for papers by Houshi Xu Breakdown of academic impact, for papers by Kenichiro Matsuda Breakdown of academic impact, for papers by Julie Dwyer Breakdown of academic impact, for papers by Jae-Bong Park Breakdown of academic impact, for papers by Brian Golbourn
Rankless by CCL
2026